Health Catalyst

Health Catalyst Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Health Catalyst (HCAT) as of Nov 10, 2026 is 52.85. In the previous year, Cash Conversion Cycle (CCC) was 42.91 — a change of 23.18% (higher).

Cash Conversion Cycle

52.85

YoY

23.18%

Last updated:

Cash Conversion Cycle (CCC) of Health Catalyst is 2025 52.85 . Cash Conversion Cycle (CCC) of Health Catalyst was 2024 42.91 . It decreases by 23.18% higher compared to the previous year.

The Health Catalyst Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
78.76 USD
Jan 1, 2019
47.47 USD
Jan 1, 2020
73.51 USD
Jan 1, 2021
59.85 USD
Jan 1, 2022
52.14 USD
Jan 1, 2023
59.59 USD
Jan 1, 2024
42.91 USD
Jan 1, 2025
52.85 USD
The Health Catalyst Cash Conversion Cycle history
YEARCash Conversion CycleYoY
52.85+23.18%
42.91-27.99%
59.59+14.30%
52.14-12.89%
59.85-18.58%
73.51+54.85%
47.47-39.73%
78.76+0.41%
78.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Health Catalyst Stock analysis

What does Health Catalyst do? Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years. Health Catalyst is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Health Catalyst stock

Cash Conversion Cycle (CCC) of Health Catalyst is 52.85 in 2025.

Cash Conversion Cycle (CCC) of Health Catalyst changed from 42.91 to 52.85, representing a 23.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Health Catalyst since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Health Catalyst with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Health Catalyst

All Key Metrics — Health Catalyst